II. Indications
- Acute medical condition
-
Medication Compliance
- Opioid, Benzodiazepine or other controlled substance prescription monitoring
- Chemical Dependency Rehabilitation
- Participation
- Employment (e.g. transportation licensing for commerical drivers, pilots)
- Military participation
- Sports participation
III. Precautions
- Urine toxicology utility has been markedly reduced by the growing use of synthetics
- Urine toxicology misses many standard substances
- Does not detect the most frequently used Benzodiazepines (Alprazolam, Clonazepam, Lorazepam)
- Variable detection of MDMA (Ecstasy)
- Does not detect semi-synthetic and synthetic Opioids
- Positive drug screen does not exclude serious other causes for Altered Mental Status
- Meningitis or Intracranial Hemorrhage may coexist with a positive Urine Drug Screen
IV. Efficacy
- Random urine drug testing may decrease Illicit Drug use in those on Chronic Opioid therapy
V. Protocol: Assess validity of real urine sample
- Urine Temperature (within 4 minutes of voiding): 90 F (32.2 C) to 100 F (37.7 C)
- Urine pH: 4.5 to 8.5 (some facilities use pH 3.0-11.0)
- Urine Creatinine: 20 mg/dl or greater (otherwise artificially diluted)
- Nitrite concentration <500 mg/dl (<4.2 mmol/L)
- Sample size 30 ml or more
VI. Protocol: Prevent urine sample tampering
- Remove outer clothing (jackets, sweatshirts, hat)
- Remove any items in urine collection area that could be used to tamper with sample (bleach, vinegar, soap, ammonia, salt)
- Remove any items from pockets
- Do not allow briefcases, backpacks, purses and other similar items in collection area
- Patient should wash and dry hands with liquid soap under observation
- Add bluing agent to toilet and turn off water to the testing area
- Observe the actual collection and use chain of custody forms to accompany the sample
- Consider split sample collections with tamper resistant containers
VII. Protocol: Urine Drug Testing Frequency in controlled substance prescription monitoring
- Predictors of misuse
- Mental health disorder
- Substance Use Disorder
- Prior Opioid misuse
- Opioid dose >120 mg Morphine Equivalents
- Lost prescriptions
- Multiple requests for early refills
- Opioid prescriptions from multiple physicians
- Unauthorized dose increases
- Intoxication at visit
- Low risk of misuse
- Urine drug test every 6 to 12 months
- Moderate risk of misuse
- Urine drug test every 3 to 6 months
- High risk of misuse
- Urine drug test every 1 to 3 months
- References
- WSAMDG Guideline on Prescribing Opioids for Pain
VIII. Labs
- Screening Basic Qualitative Urine Immunoassay (typically 5 Drug Class)
- Reference Lab Confirmatory testing (gas chromatography or high performance liquid chromatography)
- Indicated for positive results and unexpected negative results
- Specific immunoassay examples
- Synthetic and Semisynthetic Opioids (e.g. Methadone, Buprenorphine, Oxycodone, Fentanyl)
- Benzodiazepines not found on immunoassay (e.g. Alprazolam, Lorazepam, Clonazepam)
- Synthetic Cannabinoids (e.g. K2, Spice)
- Cathinones (bath salts)
- Hallucinogens (N-Bomb)
IX. Preparations: Sedatives and Hypnotics
-
Alcohol (Ethanol)
- Detection Positive: 3 to 10 hours
-
Barbiturates
- Detection
- Short-Actings agents: 1-2 days
- Long-acting agents (e.g. Phenobarbital): 21 days
- Causes: False Positive tests
- Detection
-
Benzodiazepines
- See Benzodiazepine Metabolism
- Many hospital-based Urine Drug Screens only detect Oxazepam and its precursors (Diazepam, Librium)
- These Urine Drug Screens miss Alprazolam, Clonazepam, Lorazepam, Flunitrazepam (Rohypnol)
- Detection (high doses may be detectable up to 6 weeks)
- Short-acting agents (e.g. Lorazepam, Alprazolam): 3-5 days
- Long acting agents (Clonazepam, Diazepam): 30 days
- Zolpidem (Ambien): 1 to 5 days
- Analytes
- Alpha-hydroxyalprazolam
- 7-Aminoclonazepam
- Oxazepam
- Causes: False Positive tests
X. Preparations: Stimulants - Cocaine
- Detection Direct: 5 hours
- Analytes (metabolites): Benzoylecgonine, Ecgonine methyl ester
- Detection Metabolites: 2-4 days (may persist as long as 8 days with heavy use)
- Causes: False Positive tests
- Coca leaf tea
- Topical Anesthetics containing Cocaine
XI. Preparations: Stimulants - Bath Salts
- Not detected by routine Urine Drug Screening
- Liquid and gas chromatography-mass spectrometry may detect bath salts and other synthetics
- Not widely available, expensive and prolonged test turn-around time
XII. Preparations: Stimulants - Amphetamine or Methamphetamine
- Positive: 1 to 3 days
- Detects Amphetamine at 500 ng/ml in Urine Drug Screen (and 250 ng/ml in confirmatory testing)
- Detects Methamphetamine at 250 ng/ml in Urine Drug Screen
- Decreased urine Test Sensitivity with large bicarbonate ingestions
- May also detect MDMA
- Causes: False Positive tests
- Amantadine
- Benzphetamine (Regimex)
- Brompheniramine
- Bupropion (Wellbutrin)
- Chlorpromazine
- Chloroquine
- Desipramine
- Doxepin
- Fluoxetine (Prozac)
- Labetalol
- Levomethamphetamine (OTC nasal Decongestant sprays)
- Methylphenidate (Ritalin)
- MDMA
- Phentermine
- Phenylephrine
- Phenylpropanolamine
- Promethazine (Phenergan)
- Pseudoephedrine
- Ranitidine (Zantac)
- Selegiline
- Thioridazine
- Trazodone
- Trimethobenzamide (Tigan)
- Trimipramine (Surmontil)
- Venlafaxine (Effexor)
- Vicks Inhaler
XIII. Preparations: Opioids
- See Opioid Metabolism
- Tests
- Gas chromatography: Detects all Opioids
- Enzyme linked assays:
- Reliably detects naturally occurring Opiates (Opioid subset)
- Misses semi-synthetic Opioids (structurally similar to Opiates)
- Hydrocodone
- Oxycodone
- Hydromorphone
- Oxymorphone
- Fentanyl
- Misses synthetic Opioids
- Preparations
- Codeine
- Detection Positive: 1 to 2 days
- May be detected as analytes: Morphine, Hydromorphone
- Heroin (detected as Morphine on less specific testing)
- Hydromorphone (Dilaudid)
- Detection Positive: 1 to 2 days (up to 4 days in some cases)
- Methadone (Dolophine)
- Detection Positive: 3 to 4 days (up to 14 days in some cases)
- Analytes: 2-ethylidene-1,5-dimethyl-3, 3-Diphenylpyrrolidine
- Propoxyphene (Darvon)
- Detection
- Direct: 6 hours
- Metabolites: 6 to 48 hours
- Detection
- Fentanyl
- Detection positive: 2 to 3 days (up to 4 days in some cases)
- Analytes: Norfentanyl
- Hydrocodone (e.g. Vicodin)
- Dectection positive: 1 to 2 days
- May be detected as Hydromorphone (metabolite)
- Oxycodone (e.g. Percocet)
- Detection positive: 1 to 1.5 days (up to 3 days for controlled release)
- Analytes: Noroxycodone, noroxymorphone, Oxycodone, oxymorphone
- Oxymorphone (Opana)
- Detection positive: 1.5 to 2.5 days (up to 4 days for controlled release)
- Analytes: Noroxymorphone
- Morphine
- Detection Positive: 2-3 days
- Analytes: Codeine, Hydromorphone
- Tapentadol (Nucynta)
- Detection Positive: 1 to 5 days
- Analytes: Tapentadol O-Sulfate
- Tramadol
- Detection Positive: 2-4 days
- Analytes: Nortramadol
- Buprenorphine (by specific reference testing)
- Detection at up to 11 days
- Analytes include Norbuprenorphine
- Codeine
-
False Positives
- Chlorpromazine (Methadone)
- Clomipramine (Methadone)
- Dextromethorphan (Codeine or Morphine)
- Diphenhydramine (Methadone)
- Doxylamine (Methadone)
- Fluoroquinolones (esp. Ofloxacin, Levofloxacin positive for Codeine or Morphine)
- Poppy seeds (requires very high concentration, unlikely to occur with typical food intake)
- Quetiapine (Methadone)
- Quinine (Codeine or Morphine)
- Quinolones
- Rifampin (Codeine or Morphine)
- Thioridazine (Methadone)
- Verapamil (Methadone)
XIV. Preparations: Hallucinogenics - PCP (Phencyclidine)
- Detection
- Positive: 2 to 8 days (may persist as long as 14-28 days in some cases of chronic use)
- Causes: False Positive tests
XV. Preparations: Marijuana (THC metabolite, Cannabinoids)
-
General
- Marijuana is lipophilic and is detectable for long periods after last use
- Synthetic Marijuanas are not positive on Urine Drug Screens
- Second hand Marijuana smoke does not cause a positive result (50 ng/ml or more)
- Positive test would require extreme exposures at high room concentrations
- Cone (2015) J Anal Toxicol 39(1): 1-12 [PubMed]
- Analytes
- 11-nor-9-carboxy-Tetrahydrocannabinol
- Detection
- Positive Urine
- Single use: 2 days (up to 7 days)
- Use 3-4 times per week: 7 days (up to 14 days)
- Used Daily: 2 to 4 weeks
- Long-term, heavy use: 4-6 weeks (up to 12 weeks)
- Positive Blood: 8 hours
- Positive Urine
- Causes: False Positive tests
- Dronabinol (Marinol)
- Cannabidiol (CBD) if impure (e.g. trace amounts of THC)
- NSAIDS (especially Ibuprofen, Naproxen, Sulindac)
- Hemp containing foods
- Proton Pump Inhibitors (e.g. Pantoprazole)
- Efavirenz (Sustiva)
XVI. Preparations: Miscellaneous Agents
-
Methaqualone (Quaalude)
- Positive: 2 weeks
-
Rohypnol
- Positive: 72 hours
- GHB
- Positive: 6-12 hours
-
Soma
- Detected as Meprobamate (metabolite)
XVII. Causes: Adulterants that prevent drug detection in urine
- Acetic Acid (Vinegar)
- Decreases Test Sensitivity for Tetrahydrocannabinol (THC)
- Ammonia
- Masks detection of benzoylecgonine and Phencyclidine
- Benzalkonium chloride (Visine eye drops)
- Decreases Test Sensitivity for Tetrahydrocannabinol (THC)
-
Diuretics with water intake
- Dilutes urine to undetectable substance concentrations
- Sodium Hypochlorite (Bleach)
- Masks immunoassay and may also breakdown metabolites for gas chromatography
- Glutaraldehyde (Urinaid, Clean-X)
- Decreases immunoassay Test Sensitivity for several substances
- Goldenseal (Hydrastis canadensis)
- Herbal Diuretic that dilutes urine and decreases immunoassay sensitivity to Amphetamines, THC
-
Potassium Nitrite (Klear or Whizzies)
- Decreases immunoassay, gas chromatography, mass spectrometry Test Sensitivity
- Pyridium chlorochromate (Urine Luck, Instant Clean Add-it-ive)
- Oxidizing Agent that decreases immunoassay, gas chromatography, mass spectrometry sensitivity
- Powdered urine (Dry human urine residue)
- Substitutes a clean urine for the patient's urine
- Peroxide and Peroxidase (Stealth)
- Masks immunoassay for THC and Opioids
- Other agents used
- References
XVIII. Costs
- Typical screening immunoassay costs $128 ($62 to $308)
- Insurance coverage is variable
XIX. Resources
- Clinical Drug Testing in Primary Care
XX. References
- (2014) PL Detail-Document, Urine Drug Testing, Prescriber's Letter
- Jaffee (2007) J Subst Abuse Treat 33(1): 33-42 [PubMed]
- Kale (2019) Am Fam Physician 99(1):33-9 [PubMed]
- Moeller (2008) Mayo Clin Proc 83(1): 66-76 [PubMed]
- Smith (2016) Clin Lab Med 36(4):663-71 [PubMed]
- Standridge (2010) Am Fam Physician 81(5): 635-40 [PubMed]